Gregory C. Williams

Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis

Paul D. Miller, Gary Hattersley, Bente Juel Riis et al. · JAMA · 2016 · 847 citations · Full text

Medicine, Orthopedic Surgery, Pharmacotherapy +17

ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis

Henry G. Bone, Felicia Cosman, Paul D. Miller et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 201 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16

Uclacyanins, stellacyanins, and plantacyanins are distinct subfamilies of phytocyanins: Plant‐specific mononuclear blue copper proteins

Aram M. Nersissian, Joan Selverstone Valentine, Chad E. Immoos et al. · Protein Science · 1998 · 176 citations

Life Sciences, Plant Biology, Plant Sciences +10

Oral absorption of the HIV protease inhibitors: a current update

Gregory C. Williams, Patrick J. Sinko · Advanced Drug Delivery Reviews · 1999 · 135 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis

Felicia Cosman, Paul D. Miller, Gregory C. Williams et al. · Mayo Clinic Proceedings · 2017 · 129 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16